Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.
Freemantle
Nick
N
Department of Primary Care and General Practice, Primary Care Clinical Sciences Building, University of Birmingham Edgbaston, Birmingham B15 2TT UK. n.freemantle@bham.ac.uk
Blonde
Lawrence
L
Duhot
Didier
D
Hompesch
Marcus
M
Eggertsen
Robert
R
Hobbs
F D Richard
FD
Martinez
Luc
L
Ross
Stuart
S
Bolinder
Björn
B
Stridde
Elmar
E
D000280:Administration, Inhalation; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care
D001786:Blood Glucose; C473734:Exubera; D007004:Hypoglycemic Agents; D007328:Insulin